Literature DB >> 29729379

Improved anticancer properties of stem cells derived exosomes by prolonged release from PCL nanofibrous structure.

Zahra Rezaie1, Abdolreza Ardeshirylajimi2, Mahmood Dehghani Ashkezari3.   

Abstract

Systemic chemotherapy as a routine method for the treatment of cancers has several complications. Localized chemotherapy can significantly increase the treatment efficacy and reduce side effects. Here, mesenchymal stem cells derived microvesicles (MVs) was incorporated into Polycaprolactone nanofibers and then the apoptotic behavior of MCF-7 breast cancer cells was investigated while cultured on MVs-Polycaprolactone by using SEM, MTT and apoptotic gene expression. Results demonstrated that MVs-Polycaprolactone group was shown a great apoptosis induction potential into MCF-7 cells and it can be concluded that MVs-Polycaprolactone has a great promising potential to introduce as an in-situ tumor inhibitor construct rather than chemo-drugs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Mesenchymal stem cells; Microvesicles; Polycaprolactone

Mesh:

Substances:

Year:  2018        PMID: 29729379     DOI: 10.1016/j.gene.2018.05.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.

Authors:  Hongxiang Wei; Jinyuan Chen; Shenglin Wang; Feihuan Fu; Xia Zhu; Chaoyang Wu; Zhoujie Liu; Guangxian Zhong; Jianhua Lin
Journal:  Int J Nanomedicine       Date:  2019-11-01

Review 2.  Mesenchymal/stromal stem cells: necessary factors in tumour progression.

Authors:  Xinyu Li; Qing Fan; Xueqiang Peng; Shuo Yang; Shibo Wei; Jingang Liu; Liang Yang; Hangyu Li
Journal:  Cell Death Discov       Date:  2022-07-22

Review 3.  Mesenchymal Stem Cell-Derived Extracellular Vesicles: Pleiotropic Impacts on Breast Cancer Occurrence, Development, and Therapy.

Authors:  Yiling Guo; Yujia Zhai; Longyuan Wu; Yazhuo Wang; Puzhen Wu; Lixia Xiong
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.